Takeda Pharmaceutical
TAK
$15.80
Share price
-1.06%
Change (1 day)
5.83%
Change (1 year)
Categories
Market capitalization of Takeda Pharmaceutical (TAK)
Market cap: $49.81 Billion
As of February 2023 Takeda Pharmaceutical has a market cap of $49.81 Billion. This makes Takeda Pharmaceutical the world's 336th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Takeda Pharmaceutical from 2008 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $49.81 B | 2.7% |
| 2022 | $48.50 B | 13.56% |
| 2021 | $42.71 B | -24.96% |
| 2020 | $56.92 B | -8.14% |
| 2019 | $61.96 B | 136.23% |
| 2018 | $26.23 B | -40.77% |
| 2017 | $44.29 B | 35.96% |
| 2016 | $32.57 B | -17.68% |
| 2015 | $39.57 B | 19.85% |
| 2014 | $33.02 B | -9.04% |
| 2013 | $36.30 B | 2.57% |
| 2012 | $35.39 B | 1.67% |
| 2011 | $34.81 B | -9.45% |
| 2010 | $38.44 B | 18.49% |
| 2009 | $32.44 B | -29.16% |
| 2008 | $45.79 B |
End of Day market cap according to different sources
On Feb 6th, 2023 the market cap of Takeda Pharmaceutical was reported to be:
$49.81 Billion
$49.81 Billion
$49.10 Billion
$49.99 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $427.10 B | 757.42% | 🇺🇸 USA |
 Novartis NVS | $183.74 B | 268.88% | 🇨🇭 Switzerland |
 Pfizer PFE | $245.63 B | 393.13% | 🇺🇸 USA |
 Amgen AMGN | $130.21 B | 161.41% | 🇺🇸 USA |
 Sanofi SNY | $119.42 B | 139.74% | 🇫🇷 France |
 Merck MRK | $263.75 B | 429.50% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $72.35 B | 45.25% | 🇬🇧 UK |
 Seagen
SGEN | $25.25 B | -49.31% | 🇺🇸 USA |
 Dr. Reddy's RDY | $8.79 B | -82.34% | 🇮🇳 India |